NEW YORK (GenomeWeb) – Enzo Biochem today said that PerkinElmer will pay the firm $7 million as part of a legal settlement reached between the firms last week.

The settlement ends a patent dispute dating back more than a decade. PerkinElmer was one of several defendants named by Enzo in a patent infringement suit initially filed in 2002 in the US District Court for the Southern District of New York. The case surrounded patents licensed to Enzo covering the labeling, hybridizing, and detection of nucleotides.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.